Results 291 to 300 of about 26,337,030 (428)
The use of artificial intelligence to identify ophthalmic biomarkers in cardiovascular disease and stroke: a narrative review. [PDF]
Sao Paulo Med JMartins DGDS, Martins TGDS, Schor P.
europepmc +1 more source
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Molecular Oncology, EarlyView.Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson +11 more
wiley +1 more source
Noncommunicable diseases and dental diseases
Indian Journal of Dental Research, 2018 openaire +4 more sources
On the Physics of Disease, and the Physical Pathology of the Blood [PDF]
B. W. Richardson
openalex +1 more source
Contolling Multidrug Resistant Drug Resistant Organisms (MDROs)- Is the Juice Worth the Squeeze? [PDF]
, 2018 Muto, Carlene, MD, MS
core +1 more source
Macrophage plasticity, polarization, and function in health and disease
Journal of Cellular Physiology, 2018 A. Shapouri-Moghaddam +9 more
semanticscholar +1 more source
Time to classify: a narrative and scoping review of the old and the new classifications of perianal Crohn's disease. [PDF]
Tech ColoproctolPelly T +7 more
europepmc +1 more source
Molecular Oncology, EarlyView.Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu +11 more
wiley +1 more source